These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2364386)

  • 1. Conditioning: a new approach to immunotherapy.
    Ghanta VK; Hiramoto NS; Solvason HB; Soong SJ; Hiramoto RN
    Cancer Res; 1990 Jul; 50(14):4295-9. PubMed ID: 2364386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioning of the secondary cytotoxic T-lymphocyte response to YC8 tumor.
    Ghanta VK; Hiramoto NS; Soong SJ; Hiramoto RN
    Pharmacol Biochem Behav; 1995 Mar; 50(3):399-403. PubMed ID: 7617678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.
    Colombo MP; Parenza M; Parmiani G
    Cancer Immunol Immunother; 1985; 20(3):198-204. PubMed ID: 3851699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells.
    Sensi M; Grazioli L; Parmiani G
    Cancer Immunol Immunother; 1986; 21(3):199-204. PubMed ID: 2938737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A behavioral augmentation of natural immunity: odor specificity supports a Pavlovian conditioning model.
    Solvason HB; Ghanta VK; Lorden JF; Soong SJ; Hiramoto RN
    Int J Neurosci; 1991 Dec; 61(3-4):277-88. PubMed ID: 1824390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of conditioned natural immunity on tumor growth.
    Ghanta V; Hiramoto RN; Solvason B; Spector NH
    Ann N Y Acad Sci; 1987; 496():637-46. PubMed ID: 3474995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioning of the allogeneic cytotoxic lymphocyte response.
    Hiramoto RN; Hsueh CM; Rogers CF; Demissie S; Hiramoto NS; Soong SJ; Ghanta VK
    Pharmacol Biochem Behav; 1993 Feb; 44(2):275-80. PubMed ID: 8446660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium carbonate prevents NK cell conditioning by interfering with the US signal.
    Rogers C; Ghanta V; Demissie S; Hiramoto N; Hiramoto R
    Int J Neurosci; 1994 Aug; 77(3-4):277-86. PubMed ID: 7814220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiple modality approach combining the effect of conditioning with adoptive chemoimmunotherapy.
    Ghanta VK; Hiramoto NS; Soong SJ; Miller DM; Hiramoto RN
    Int J Neurosci; 1993; 71(1-4):251-65. PubMed ID: 8407150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune enhancement by conditioning of senescent mice. Comparison of old and young mice in learning ability and in ability to increase natural killer cell activity and other host defense reactions in response to a conditioned stimulus.
    Spector NH; Provinciali M; di Stefano G; Muzzioli M; Bulian D; Viticchi C; Rossano F; Fabris N
    Ann N Y Acad Sci; 1994 Nov; 741():283-91. PubMed ID: 7825816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cells.
    Fefer A
    Cancer Res; 1973 Apr; 33(4):641-4. PubMed ID: 4696464
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy with allogeneic immune peritoneal cells.
    Dullens HF; Den Otter W
    Cancer Res; 1974 Jul; 34(7):1726-30. PubMed ID: 4833917
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of immune cells in the Pavlovian conditioning of specific resistance to cancer.
    Hiramoto RN; Hiramoto NS; Rish ME; Soong SJ; Miller DM; Ghanta VK
    Int J Neurosci; 1991 Jul; 59(1-3):101-17. PubMed ID: 1774131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditioned augmentation of natural killer cell activity. Independence from nociceptive effects and dependence on interferon-beta.
    Solvason HB; Ghanta VK; Hiramoto RN
    J Immunol; 1988 Jan; 140(2):661-5. PubMed ID: 2826599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of adoptive immunotherapy by cis-diamminedichloroplatinum(II), but not by doxorubicin, on a disseminated mouse lymphoma and its association with reduction of tumor burden.
    Formelli F; Rossi C; Sensi ML; Parmiani G
    Int J Cancer; 1988 Dec; 42(6):952-7. PubMed ID: 3263956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of natural immunity and regulation of tumor growth by conditioning.
    Ghanta VK; Miura T; Hiramoto NS; Hiramoto RN
    Ann N Y Acad Sci; 1988; 521():29-42. PubMed ID: 3377365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the YC8 lymphoma growth by alloimmunization with normal cells.
    Parmiani G; Sensi ML
    Transplant Proc; 1981 Dec; 13(4):1906-9. PubMed ID: 7330975
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L; Fefer A
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.